A pilot study of client progress in short-term drug abuse treatment

Journal of Psychoactive Drugs
D C BellR T Spence

Abstract

This paper is a pilot study of client progress in two short-term (23-day) drug abuse treatment programs. Client progress is defined as those changes in cognitive functioning, emotional well-being, and social support resources that are th proximate goals of drug abuse treatment. In this study, client progress was measured by changes in cognitive functioning, emotional well-being, and social support domains over the course of treatment. This pilot study showed that client progress can be detected in short-term treatment and can be related to indicators of the quantity and quality of treatment. In general, results showed that both relationships and emotional well-being changed over the course of treatment. Cognitive functioning variables did not generally change over time, nor were they related to indicators of treatment quality. Evidence in this pilot study suggests that more attention needs to be given to the relational and emotional aspects of the drug abuse treatment process.

References

Feb 1, 1975·Archives of General Psychiatry·G E Vaillant
Jan 1, 1990·Clinical and Experimental Hypertension. Part A, Theory and Practice·G A SagnellaG A MacGregor
Jan 1, 1989·The American Journal of Drug and Alcohol Abuse·T JacobR H Rushe
Apr 1, 1985·The International Journal of the Addictions·J C DeanW Jensen
May 1, 1987·British Journal of Addiction·A Skutle, G Berg
Jan 1, 1986·Advances in Alcohol & Substance Abuse·M Galanter
Nov 1, 1985·The American Journal of Psychiatry·E J Khantzian
Jan 1, 1985·Breast Cancer Research and Treatment·W R MillerA A Shivas
Jan 1, 1974·Journal of the American Psychoanalytic Association·L Wurmser
Feb 1, 1974·The American Journal of Psychiatry·E J KhantzianA F Schatzberg
Mar 1, 1984·The Journal of Nervous and Mental Disease·S J BlattH D Kleber
Jan 1, 1980·Journal of Gerontological Nursing·J C Rogers
Sep 1, 1980·Journal of Toxicology and Environmental Health·L Fishbein
Jan 1, 1982·Journal of Psychoactive Drugs·E Coleman
Mar 1, 1980·Social Science & Medicine. Medical Psychology & Medical Sociology·D P Mueller
Jan 1, 1980·Journal of Applied Behavior Analysis·A E Kazdin
Jun 1, 1980·Social Science & Medicine. Medical Geography·C C Johnston
May 1, 1993·Drug and Alcohol Dependence·M Y IguchiR R Griffiths
Mar 1, 1994·The International Journal of the Addictions·D C Bell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.